IN.PACT™ Admiral™ ADM06012013P (UDI 00643169859975)Recalls & reported problems
Medtronic, Inc. · DEB ADM06012013P 06.00 L120 UL1300 US · Class 3
All models of IN.PACT Admiral (39)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 7
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00643169859975), received between Jan 9, 2018 and Apr 24, 2024 — classified as 1 death, 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Deflation Problem” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Mar 23, 2022Class IIOpen, Classified
Packaging for Balloon Catheters may be damaged resulting in loss of sterility.
Z-1042-2022 · Root cause: Packaging process control · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Deflation Problem2
- Burst Container or Vessel1
- Compatibility Problem1
- Inflation Problem1
- Leak/Splash1
Patient problems
- No Consequences Or Impact To Patient3
- Vascular Dissection2
- Death1
- No Clinical Signs, Symptoms or Conditions1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryApr 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE INDEX PROCEDURE A IN.PACT ADMIRAL WAS USED TO TREAT THE SUPERFICIAL FEMORAL MIDDLE, SUPERFICIAL FEMORAL DISTAL. IMMEDIATELY POST PROCEDURE PATIENT SUFFERED DISSECTION TYPE C. DURING INDEX PROCEDURE BALLOONING LESION OF RIGHT SFA WITH IN.PACT ADMIRAL DCB IMPROVED TARGETED STENOSIS, BUT THERE APPEARED TO BE A TYPE C DISSECTION. TARGET LESION INVOLVED. MD THEN BROUGHT IN A MEDTRONIC 7X120 EVERFLEX STENT FOR BAIL-OUT STENTING AS ASSESSED BY PROCEDURAL MD. STENT POST-DILATED AND RESOLVED DISSECTION. PATIENT RECOVERED.
Patient problems: Vascular Dissection
MAUDE report 19171021 ↗MalfunctionJun 30, 2021Deflation Problem; Compatibility Problem; Deflation Problem; Compatibility Problem
PHYSICIAN ATTEMPTED TO USE AN INPACT ADMIRAL DRUG COATED BALLOON WITH A NON-MEDTRONIC 6FR SHEATH DURING A PROCEDURE TO TREAT A LESION IN THE PATIENT¿S MID SUPERFICIAL FEMORAL ARTERY (SFA). AN INFLATION DEVICE WAS USED FOR BALLOON INFLATION. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT. IT IS REPORTED THE INAPCT ADMIRAL WAS INCOMPATIBLE WITH THE 6FR SHEATH. THE PHYSICAL HAD TO PULL THE ENTIRE SHEATH WITH THE BALLOON INSIDE OUT. A SECOND SHEATH WAS THEN PLACED, AND THE PROCEDURE COMPLETED. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12092434 ↗MalfunctionMay 25, 2020Burst Container or Vessel; Burst Container or Vessel
PHYSICIAN ATTEMPTED TO USE AN INPACT ADMIRAL DURING TREATMENT OF A CTO (CHRONIC TOTAL OCCLUSION - 100%) IN THE PROXIMAL RIGHT SUPERFICIAL FEMORAL ARTERY (SFA). THE VESSEL WAS NOT TORTUOUS. ARTERY DIAMETER WAS 6 MM AND LESION LENGTH WAS APPROXIMATELY 100-120 MM. NO DAMAGE WAS NOTED TO THE DEVICE PACKAGING AND NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM HOOP/TRAY. THE DEVICE WAS INSPECTED. NEGATIVE PREP WAS PERFORMED. LESION WAS PRE-DILATED. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS FELT, NO EXCESSIVE FORCE WAS USED. IT IS REPORTED THAT A BALLOON BURST OCCURRED DURING FIRST BALLOON INFLATION AT 14 ATM. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10085049 ↗DeathMar 25, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE INDEX PROCEDURE, TWO INPACT ADMIRAL PTA BALLOON CATHETERS WERE USED TO TREAT THE RIGHT SFA. APPROXIMATELY 8 MONTHS POST INDEX PROCEDURE THE PATIENT SUFFERED VENTRICULAR FIBRILLATION AND DIED SUDDEN CARDIAC DEATH. IT WAS REPORTED THAT THE DEATH WAS DUE TO VENTRICULAR FIBRILLATION.
Patient problems: Death
MAUDE report 8448276 ↗MalfunctionDec 17, 2018Deflation Problem; Inflation Problem; Deflation Problem; Inflation Problem
THE PHYSICIAN INTENDED TO USE THE INPACT ADMIRAL WITH A NON-MEDTRONIC 6F SHEATH AND A NON-MEDTRONIC 018 GUIDEWIRE, TO TREAT A SOFT TISSUE LESION WITH 50% STENOSIS IN THE LEFT PROXIMAL SUPERFICIAL FEMORAL ARTERY. ARTERY DIAMETER 6MM, LESION LENGTH 110MM. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT, NO RESISTANCE OR EXCESSIVE FORCE WAS USED. ONE SUCCESSFUL INFLATION WAS PERFORMED TO AN INFLATION PRESSURE OF 8-14ATM¿S. BALLOON INFLATION DIFFICULTIES WERE ENCOUNTERED AND THE DEVICE WAS SLOW TO DEFLATE AT THE LESION SITE. DEFLATION TIME WAS NOT PROVIDED. BALLOON WOULD NOT HOLD STEADY PRESSURE, BUT DILATION WAS SUCCESSFUL WHILE USING CONTINUED INFLATION. REMOVAL DIFFICULTIES WERE ALSO ENCOUNTERED AFTER BALLOON INFLATION. WHEN RETRIEVING THE DEFLATED BALLOON THROUGH THE SHEATH IT WOULD NOT COMPLETELY ENTER THE DISTAL END OF THE SHEATH. THE BALLOON AND SHEATH HAD TO BE REMOVED AND A NEW SHEATH WAS PLACED AND THE PROCEDURE WAS COMPLETED. NO PATIENT INJURY REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8169659 ↗InjuryOct 23, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING TREATMENT OF MODERATELY CALCIFIED FIBROUS LESIONS WITH 80% STENOSIS IN THE DISTAL MID LEFT SUPERFICIAL FEMORAL ARTERY (ARTERY DIAMETER 6MM), PHYSICIAN FIRST PREPPED TWO LESIONS IN THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WITH A HAWKONE DIRECTIONAL ATHERECTOMY DEVICE AND THEN POST DILATED WITH TWO IN.PACT ADMIRAL BALLOONS. FOLLOWING POST-DILATION, A DISSECTION WAS NOTED IN THE DISTAL SFA AND POPLITEAL ARTERY THAT WAS DETERMINED TO REQUIRE STENTING. THE PHYSICIAN THEN USED AN EVERFLEX ENTRUST WITH A NON-MEDTRONIC 7FR. 55CM SHEATH AND A SPIDER FX 7MM EMBOLIC PROTECTION DEVICE. IT WAS REPORTED THAT STENT DEFORMATION OCCURRED IN VIVO DURING DEPLOYMENT. THE PHYSICIAN DECIDED TO POST DILATE THE STENT OVER A WHOLEY WIRE THAT WAS PLACED INSIDE THE STENTED SEGMENT. HE POST-DILATED THE STENT WITH A NON-MEDTRONIC 6X100 PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOON. THE PATIENT IS REPORTED TO BE DOING FINE AND THE FINAL ANGIOGRAM SHOWED A PATENT VESSEL WITH BETTER RUNOFF TO THE DISTAL VESSELS.
Patient problems: Patient Problem/Medical Problem; Vascular Dissection
MAUDE report 7994380 ↗MalfunctionJan 9, 2018Leak/Splash; Leak/Splash
PHYSICIAN INTENDED TO USE AN IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER FOR THE TREATMENT OF A MODERATELY CALCIFIED PLAQUE LESION IN THE SUPERFICIAL FEMORAL ARTERY. IFU WAS FOLLOWED. DEVICE PREPPED WITHOUT ISSUE. EMBOLIC PROTECTION WAS USED. INFLATION DEVICE WAS USED. IT WAS REPORTED THAT THERE WAS A HOLE IN THE DELIVERY CATHETER SHAFT THAT WAS REALIZED UPON INITIAL INFLATION AT A PRESSURE OF 8 ATM. DEVICE WAS REPLACE WITH ANOTHER DCB AND ANGIOPLASTY WAS COMPLETED. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7177617 ↗
Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices
- LUTONIX® Drug Coated Balloon LX351305150Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter117 reports
- LUTONIX® Drug Coated Balloon LX351306150Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter75 reports
- Ranger™ H74939419502010Boston Scientific Corporation · Drug-Eluting Peripheral Transluminal Angioplasty Catheter71 reports
- Ranger™ H74939419602010Boston Scientific Corporation · Drug-Eluting Peripheral Transluminal Angioplasty Catheter71 reports
- Lutonix® Drug Coated Balloon LX351305100Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter66 reports
- IN.PACT™ Admiral™ ADM06004013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall12 reports
- IN.PACT™ Admiral™ ADM06015013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall11 reports
- IN.PACT™ Admiral™ ADM04015013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall8 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page